Part 1: 'Liquid Cytometer and Monoclonal Antibodies'

This tender concerns the procurement of reagents, specifically a liquid cytometer and monoclonal antibodies, as part of a research project. The project, titled 'Detection and Quantification of Minimal Residual Disease in Patients with Multiple Myeloma,' is funded through the Special Account for Research Funds of the National and Kapodistrian University of Athens (EKPA), under research code 14210. The contracting authority is seeking a supplier capable of providing these essential laboratory reagents. The scope of the contract includes the supply of the specified items, which are crucial for the accurate detection and quantification of minimal residual disease in patients undergoing treatment for multiple myeloma. Bidders must ensure that the supplied reagents meet the required technical specifications and quality standards for use in advanced diagnostic and research applications. The tender, referenced in section 1.3 of the tender documentation, aims to equip the research team with the necessary tools to advance their understanding and treatment of this condition.

This is a supplies contract in the health and medical services sector, with a focus on Laboratory. Located in Greece, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 103,762.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.